Elasomeran/methylphenidateMyocarditis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1904卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14139-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[31] Antiplatelets/elasomeran/rivaroxabanGross haematuria and epistaxis : 2 case reports
Reactions Weekly, 2023, 1956 (1) : 70 - 70
[32] Elasomeran/tozinameranAnaphylaxis: 7 case reports
Reactions Weekly, 2023, 1968 (1) : 136 - 136
[33] Elasomeran/tozinameranMyocarditis: 4 case reports
Reactions Weekly, 2022, 1930 (1) : 249 - 249
[34] Elasomeran/tozinameranThrombocytopenia and thrombocytopenic-purpura: 2 case reports
Reactions Weekly, 2022, 1899 (1) : 179 - 179
[35] Elasomeran/tozinameranAllergic reactions: 22 case reports
Reactions Weekly, 2022, 1908 (1) : 241 - 241
[36] Elasomeran/tozinameranTreatment failure: 3 case reports
Reactions Weekly, 2022, 1920 (1) : 210 - 210
[37] Elasomeran/tozinameranVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1948 (1) : 192 - 192
[38] Elasomeran/tozinameranVenous thromboembolism: 15 case reports
Reactions Weekly, 2022, 1918 (1) : 212 - 212
[39] Elasomeran/tozinameranNeuralgic amyotrophy: 3 case reports
Reactions Weekly, 2023, 1939 (1) : 194 - 194
[40] Elasomeran/tozinameranVarious toxicities: 8 case reports
Reactions Weekly, 2022, 1912 (1) : 202 - 202

← 1 2 3 4 5 →